Legend Biotech to Host Investor Conference Call on First Quarter 2024 Resul..
Apr 11, 2024
Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First..
Apr 05, 2024
Legend Biotech Announces Publication of Inaugural Environmental, Social and..
Mar 19, 2024
CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S..
Mar 15, 2024
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent..
Mar 11, 2024
We use cookies to improve your experience on our website, measure performance, understand our audience, for advertising and support purposes. You can always change your preferences or opt out from our use of cookies.